Condition

Nephropathy

ClinicalTrials.gov condition label

Clinical trials21
Recruiting2
Common interventions25
Lead sponsors shown15

Clinical trials

21 shown
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)NCT06837181 · 2025-09-18
RECRUITING
Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study)NCT02818192 · 2017-01-01
RECRUITING
Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxiaNCT06147232 · 2025-02-01
NOT_YET_RECRUITING
Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic NephropathyNCT06501651 · 2024-08-01
UNKNOWN
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up StudyNCT05530356 · 2022-09-30
COMPLETED
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer PatientsNCT05746598 · 2020-07-01
UNKNOWN
Effects of Probiotics and Fibers on Albuminuria in Persons With Type 1 DiabetesNCT04635670 · 2020-06-29
COMPLETED
Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 DiabetesNCT04193566 · 2020-02-01
COMPLETED
Screening for Fabry Disease in Renal TransplantationNCT03886714 · 2019-03-25
TERMINATED
Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic FunctionNCT03618420 · 2018-10-01
COMPLETED
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes StudyNCT03584217 · 2018-10-01
ACTIVE_NOT_RECRUITING
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 DiabetesNCT03620773 · 2018-10-01
COMPLETED
The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and TreatmentNCT02575092 · 2015-11-01
COMPLETED
Atrasentan Spermatogenesis and Testicular FunctionNCT02118714 · 2015-04-06
COMPLETED
Time To Complications Occurs in DiabetesNCT00969956 · 2012-04-01
TERMINATED
The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and NephropathyNCT01208701 · 2010-05-01
COMPLETED
Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus MedicinesNCT06355219 · 2010-01-01
COMPLETED
A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and MicroalbuminuriaNCT00843388 · 2009-03-01
UNKNOWN
VA NEPHRON-D: Diabetes iN Nephropathy StudyNCT00555217 · 2008-07-01
TERMINATED
Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes NephropathyNCT00655330 · 2008-05-01
UNKNOWN
A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)NCT00308347 · 1996-05-01
COMPLETED

Common interventions

Aminohippurate Sodium Inj 20%DRUG4Iohexol Inj 300 mg/mLDRUG4PlaceboDRUG3Renal BiopsyPROCEDURE3ValsartanDRUG2AtorvastatinDRUG1AtrasentanDRUG1Cisplatin injectionDRUG1Dextran 40DRUG1Enalapril Maleate and Folic Acid tablets(as the program-based antihypertension)DRUG1Enalapril Maleate Tablets(as the program-based antihypertension)DRUG1ForxigaDRUG1lisinoprilDRUG1losartanDRUG1MK0954, losartan / Duration of Treatment: mean 3.4 yearsDRUG1observational studyOTHER1PlaceboDIETARY_SUPPLEMENT1Placebo / Duration of Treatment: mean 3.4 yearsDRUG1placebo tabletDRUG1Positron Emission TomographyRADIATION1Pro-/prebiotic MixDIETARY_SUPPLEMENT1ProbucolDRUG1Sacubitril/ValsartanDRUG1Screen for α-galactosidase mutationDIAGNOSTIC_TEST1Screening for Fabry diseaseDIAGNOSTIC_TEST1

Trial status mix

COMPLETED10
UNKNOWN4
TERMINATED3
RECRUITING2
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1

Phase mix

PHASE27
PHASE13
PHASE33
PHASE43
NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.